Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives

SV Aronowitz, E Engel-Rebitzer, A Dolan… - Harm reduction …, 2021 - Springer
Background The majority of individuals with opioid use disorder (OUD) face access barriers
to evidence-based treatment, and the COVID-19 pandemic has exacerbated the United …

Low-threshold buprenorphine treatment in a syringe services program: program description and outcomes

A Jakubowski, BL Norton, BT Hayes… - Journal of addiction …, 2022 - journals.lww.com
Objectives: Low-threshold buprenorphine treatment aims to reduce barriers to evidence-
based opioid use disorder treatment. We aimed to describe the treatment philosophy …

“The new normal has become a nonstop crisis”: a qualitative study of burnout among Philadelphia's harm reduction and substance use disorder treatment workers …

IC Unachukwu, MP Abrams, A Dolan, K Oyekemi… - Harm Reduction …, 2023 - Springer
Background The COVID-19 pandemic worsened the ongoing overdose crisis in the United
States (US) and caused significant mental health strain and burnout among health care …

[HTML][HTML] Long-acting depot buprenorphine in people who are homeless: views and experiences

C Matheson, R Foster, J Schofield, T Browne - Journal of Substance Abuse …, 2022 - Elsevier
Introduction People experiencing homelessness often experience intersecting mental and
physical health problems, alongside problem substance use and a range of overlapping …

Association between adverse childhood experiences and opioid use-related behaviors: a systematic review

S Regmi, SK Kedia, NA Ahuja, G Lee… - … Violence, & Abuse, 2024 - journals.sagepub.com
As opioid use-related behaviors continue at epidemic proportions, identifying the root
causes of these behaviors is critical. Adverse childhood experiences (ACEs) are shown to …

Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective …

E Suarez, TS Bartholomew, M Plesons… - Annals of …, 2023 - Taylor & Francis
Background: At the start of the pandemic, relaxation of buprenorphine prescribing
regulations created an opportunity to create new models of medications for opioid use …

“Come try it out. Get your foot in the door:” Exploring patient perspectives on low-barrier treatment for opioid use disorder

M Lowenstein, MP Abrams, M Crowe… - Drug and Alcohol …, 2023 - Elsevier
Purpose Low-barrier treatment is an emerging strategy for opioid use disorder (OUD) care
that prioritizes access to evidence-based medication while minimizing requirements that …

Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada

C Russell, M Pang, F Nafeh… - … Journal of Qualitative …, 2022 - Taylor & Francis
Introduction Correctional populations with opioid use disorder experience increased health
risks during community transition periods. Opioid Agonist Treatment (OAT) can reduce these …

Willingness to utilize a mobile treatment unit in five counties at the epicenter of the US rural opioid epidemic

SR Peddireddy, MD Livingston III, AM Young… - Journal of Substance …, 2024 - Elsevier
Introduction US federal policies are evolving to expand the provision of mobile treatment
units (MTUs) offering medications for opioid use disorder (MOUD). Mobile MOUD services …

Health care utilization among homeless-experienced adults who were seen by a mobile addiction health clinic in Boston, Massachusetts: a quasi-experimental study

DR Fine, A Joyce, Y Chang, E Lewis… - Substance use & …, 2023 - Taylor & Francis
Background: Mobile health clinics improve access to care for marginalized individuals who
are disengaged from the healthcare system. This study evaluated the association between a …